Webinar
/
May 19, 2025

Conversations with Colin: an interview with Dr. Brad Karlin

During this session, Colin will interview Dr. Brad Karlin, Highmark Health VP and Executive Medical Director, Behavioral Health, Johns Hopkins University Adjunct Professor, Department of Mental Health, School of Public Health & Past President of the Society of Clinical Psychology.

The two will discuss the current mental health crisis and key needs and opportunities for changing how mental health care is delivered to improve access and quality.

Copy Link

Watch the replay

Here’s our latest

The crisis of adolescent mental health: creating new solutions for teens and families

Adolescent mental health concerns have reached a new scale in recent years, with serious implications for teens, their families, and society. A survey from the CDC found that in the 10 years leading up to the pandemic, feelings of persistent sadness and hopelessness increased by about 40% among young people.1 There is an increased urgency...

Webinar
Effective strategies for combating youth depression and suicidality in the digital age

As part of Suicide Prevention Awareness Month, Big Health and Vita Health came together with Solome Tibebu of Going Digital: Behavioral Health Tech to discuss preventative measures and strategies to combat depression and suicidal ideation in our adolescent population. In this replay, you will learn about new non-drug digital programs to help address the root...

Webinar
The future of mental health care: familial mental health and workplace productivity

Today’s youth mental health crisis is presenting new challenges for the one in four workers who have an adolescent with a mental health issue, resulting in a costly toll on employee productivity. HR benefit managers are pressured with ensuring their benefits support the mental wellbeing, and overall health of their employee base as well as...

Webinar

During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.

1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. https://www.nice.org.uk/advice/mib129.5. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.

DOC-3046 Effective 11/2023